Few studies involving small groups of subjects show increased mutagen sensitivity in irradiated peripheral lymphocytes of BRCA1/2 mutation carriers compared with healthy controls, but the implication of the BRCA mutation was not appreciable in other studies when the comparison was made with BC patients without a BRCA mutation, suggesting a major role of cancer status in mutagen sensitivity. The gene discussed is BRCA1; the disease is breast cancer.